Taking a look on fungi in cystic fibrosis: More questions than answers

Rev Iberoam Micol. 2020 Jan-Mar;37(1):17-23. doi: 10.1016/j.riam.2019.10.004. Epub 2020 Jan 9.

Abstract

Cystic fibrosis (CF) is one of the most frequent recessive inherited diseases in western countries. Advances in medical care have led to a substantial increase in the life expectancy of CF patients. Survival beyond adolescence has permitted to see fungi not only as late colonizers, but also as potential pathogens responsible of allergic reactions and chronic infections related to lung function deterioration. The role of fungi, nevertheless, has been overlooked until recently. As a result, a number of questions on their epidemiology, clinical significance, or diagnosis, among others, remain unanswered. Besides more in depth studies about the extent of the deleterious effect of fungi on the CF host, new technologies may provide the key to understand its pathogenic role, its interaction with other microbial components of the respiratory microbiota, and should pave the way to define subsets of patients at risk who would benefit from specific therapy. This review is intended to provide a quick overview on what we know about the presence of fungi in the CF airway and its repercussion in the host, and to point out some of the many knowledge gaps needed to understand and advance in the management of fungi in the airway of CF subjects.

Keywords: Cystic fibrosis; Enfermedad relacionada con hongos; Fibrosis quística; Fungal-related pathology; Hongos asociados al tracto respiratorio; Respiratory tract-associated fungi.

Publication types

  • Review

MeSH terms

  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / microbiology*
  • Fungi / isolation & purification*
  • Humans
  • Mycoses / complications*
  • Respiratory System / microbiology